DL-3-n-butylphthalide (NBP) alleviates poststroke cognitive impairment (PSCI) by suppressing neuroinflammation and oxidative stress
Open Access
- 11 January 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 987293
Abstract
Currently, the recovery of cognitive function has become an essential part of stroke rehabilitation. DL-3-n-butylphthalide (NBP) is a neuroprotective reagent and has been used in stroke treatment. Clinical studies have confirmed that NBP can achieve better cognitive outcomes in ischemic stroke patients than in healthy controls. In this study, we aimed to investigate the influences of NBP on cognitive function in an ischemic reperfusion (I/R) rat model. Our results showed that NBP profoundly decreased neurological scores, reduced cerebral infarct areas and enhanced cerebral blood flow (CBF). NBP potently alleviated poststroke cognitive impairment (PSCI) including depression-like behavior and learning, memory and social cognition impairments, in I/R rats. NBP distinctly suppressed the activation of microglia and astrocytes and improved neuron viability in the ischemic brain. NBP inhibited the expression of inflammatory cytokines, including interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), by targeting the nuclear factor kappa B/inducible nitric oxide synthase (NF-κB/iNOS) pathway and decreased cerebral oxidative stress factors, including reactive oxygen species (ROS) and malondialdehyde (MDA), by targeting the kelch like ECH associated protein 1/nuclear factor-erythroid 2 p45-related factor 2 (Keap1/Nrf2) pathway in the ischemic brain. The current study revealed that NBP treatment improved neurological function and ameliorated cognitive impairment in I/R rats, possibly by synergistically suppressing inflammation and oxidative stress.Keywords
This publication has 47 references indexed in Scilit:
- The edaravone and 3-n-butylphthalide ring-opening derivative 10b effectively attenuates cerebral ischemia injury in ratsActa Pharmacologica Sinica, 2015
- Chlorella Ethanol Extract Induced Phase II Enzyme Through NFE2L2 (Nuclear Factor [Erythroid-Derived] 2-Like 2, NRF2) Activation and Protected Ethanol-Induced HepatoxicityJournal of Medicinal Food, 2015
- Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: From review to previewClinical Neurology and Neurosurgery, 2015
- Interleukin-17 in post-stroke neurodegenerationNeuroscience & Biobehavioral Reviews, 2013
- Attenuation of oxidative stress, neuroinflammation, and apoptosis by curcumin prevents cognitive deficits in rats postnatally exposed to ethanolPsychopharmacology, 2012
- The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairmentJournal of Neuroinflammation, 2011
- Sesamol Suppresses Neuro-Inflammatory Cascade in Experimental Model of Diabetic NeuropathyThe Journal of Pain, 2010
- Suppression of neuro-inflammatory signaling cascade by tocotrienol can prevent chronic alcohol-induced cognitive dysfunction in ratsBehavioural Brain Research, 2009
- Use of an Optimized Transient Occlusion of the Middle Cerebral Artery Protocol for the Mouse Stroke ModelJournal of Stroke and Cerebrovascular Diseases, 2006
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989